MYELOPROLIFERATIVE OVERLAP NEOPLASMS

Clinical trials for MYELOPROLIFERATIVE OVERLAP NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new MYELOPROLIFERATIVE OVERLAP NEOPLASMS trials appear

Sign up with your email to follow new studies for MYELOPROLIFERATIVE OVERLAP NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug combo tested for Tough-to-Treat blood cancers

Disease control Not yet recruiting

This early-stage study is testing whether adding an oral drug called momelotinib to a standard injected therapy (azacitidine) is safe and effective for people with certain rare, overlapping blood cancers. The goal is to better control the disease, reduce symptoms like an enlarged…

Matched conditions: MYELOPROLIFERATIVE OVERLAP NEOPLASMS

Phase: EARLY_PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control

Last updated Mar 19, 2026 14:55 UTC

MYELOPROLIFERATIVE OVERLAP NEOPLASMS

Get alerted when new MYELOPROLIFERATIVE OVERLAP NEOPLASMS trials appear

New drug combo tested for Tough-to-Treat blood cancers